CD80 and neoplasm: At first, in order to attack and eliminate tumor cells, APCs, via CD28-CD80/CD86 pathway, activate T cells, but at the same time regulate pro-inflammatory mechanisms, activating inhibitory pathways by immune checkpoints (28).